MedTech research and development company Medinol Inc announced on Thursday that its subsidiary Microtech has started human clinical trials of its microsensor platform, in a trial to assess atrial pressures important for the treatment of heart failure.

The first implantation was recently conducted by Prof. Erez Sharoni at Beilinson Medical Centre in Petah-Tikva, Israel.

The Microtech implantable microsensor platform is the result of decades of development in a new class of sensor technology that can be used both as a stand-alone device or integrated with existing devices.

Prof. Sharoni, head of Cardio-Thoracic Surgery, said: "This amazing technology may change the standard of care for patients suffering from heart failure and in particular, in this current study, those who are receiving LVADs or heart transplants."